Rafikova, G.,
Piatnitskaia, S.,
Shapovalova, E.,
Chugunov, S.,
Kireev, V.,
Ialiukhova, D.,
Bilyalov, A.,
Pavlov, V.,
Kzhyshkowska, J. (2023) modifications of the basic
material, surface structures and
modifications, implant shapes and porosity. We
Kudriashov, Valentin,
Sufianov, Albert,
Mashkin, Andrey,
Beilerli, Aferin,
Ilyasova, Tatiana,
Liang, Yanchao,
Lyulin, Sergey,
Beylerli, Ozal (2023) by many factors,
including epigenetic ones. Histone
modifications, DNA methylation, and non-coding RNAs
Sufianov, A.,
Beilerli, A.,
Kudriashov, V.,
Ilyasova, T.,
Liang, Ya.,
Mukhamedzyanov, A.,
Bessonova, M.,
Mashkin, A.,
Beylerli, O. (2023) by modulating the levels of visible
modification, transcription, post-transcription, and biological environment
Shnayder, Natalia A.,
Ashhotov, Azamat V.,
Trefilova, Vera V.,
Novitsky, Maxim A.,
Medvedev, German V.,
Petrova, Marina M.,
Narodova, Ekaterina A.,
Kaskaeva, Daria S.,
Chumakova, Galina A.,
Garganeeva, Natalia P.,
Lareva, Natalia V.,
Al-Zamil, Mustafa,
Asadullin, Azat R.,
Nasyrova, Regina F. (2023) engineering); genetic technologies (gene
modifications, microRNA, and molecular inducers of IDD); technologies
Sufianov, A.,
Beilerli, A.,
Begliarzade, S.,
Ilyasova, T.,
Kudriashov, V.,
Liang, Y.,
Beylerli, O. (2023) of cells, epigenetic
modifications, apoptosis, as well as in complex control and pathogenesis of various
modifications), SIRT6, cytidine
deaminases APOBEC3, APOBEC1, and other catalytic proteins, such as ERCC, TREX1
Mead, Gillian E,
Sposato, Luciano A,
Sampaio Silva, Gisele,
Yperzeele, Laetitia,
Wu, Simiao,
Kutlubaev, Mansur,
Cheyne, Joshua,
Wahab, Kolawole,
Urrutia, Victor C,
Sharma, Vijay K,
Sylaja, PN,
Hill, Kelvin,
Steiner, Thorsten,
David S, Liebeskind,
Rabinstein, lejandro A (2023) modification; and for ischemic stroke, management of atrial fibrillation, valvular heart disease, left